271 related articles for article (PubMed ID: 3792640)
1. Reduction of animal usage: British Pharmacopoeia Commission policy.
Rabouhans ML
Dev Biol Stand; 1986; 64():11-6. PubMed ID: 3792640
[TBL] [Abstract][Full Text] [Related]
2. Replacement, Reduction, Refinement - Animal welfare progress in European Pharmacopoeia monographs: activities of the European Pharmacopoeia Commission from 2007 to 2017.
Lang C; Kolaj-Robin O; Cirefice G; Taconet L; Pel E; Jouette S; Buda M; Milne C; Charton E
Pharmeur Bio Sci Notes; 2018; 2018():12-36. PubMed ID: 29845933
[TBL] [Abstract][Full Text] [Related]
3. Alternatives to animals in the development and control of biological products for human and veterinary use. The role of the European Pharmacopoeia.
Artiges A
Dev Biol Stand; 1999; 101():29-35. PubMed ID: 10566772
[TBL] [Abstract][Full Text] [Related]
4. Alternatives to animal testing: achievements and recent developments in the European Pharmacopoeia.
Castle P
Dev Biol Stand; 1996; 86():21-9. PubMed ID: 8785951
[TBL] [Abstract][Full Text] [Related]
5. [Animal experiments in the context of quality control of pharmaceuticals. Review of the European Pharmacopoeia, 4th edition, 2002].
Sponer G
ALTEX; 2004; 21(2):73-80. PubMed ID: 15195228
[TBL] [Abstract][Full Text] [Related]
6. [Microbiological and biological methods of the European Pharmacopoeia. Relevant for each medicinal product].
Norwig J
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1158-68. PubMed ID: 25200487
[TBL] [Abstract][Full Text] [Related]
7. Three Rs potential in the development and quality control of immunobiologicals.
Halder M
ALTEX; 2001; 18 Suppl 1():13-47. PubMed ID: 11854853
[TBL] [Abstract][Full Text] [Related]
8. Hormones: the role of the European Pharmacopoeia.
Charton E
Dev Biol Stand; 1999; 101():159-67. PubMed ID: 10566789
[No Abstract] [Full Text] [Related]
9. Pyrogen testing of lipidic parenterals with a novel in vitro test--application of the IPT based on cryopreserved human whole blood.
Schindler S; Rosenberg U; Schlote D; Panse K; Kempe A; Fennrich S; Hartung T
Pharmeur Sci Notes; 2006 Aug; 2006(1):1-7. PubMed ID: 17694639
[TBL] [Abstract][Full Text] [Related]
10. Pharmacopoeia as quality codex for the manufacturers.
Soldi A
Ann Ist Super Sanita; 1975; 11(3-4):269-80. PubMed ID: 1234728
[TBL] [Abstract][Full Text] [Related]
11. Establishment of European Pharmacopoeia (Ph. Eur.) Biological Reference Preparations (BRP) batch 2 for rDNA hepatitis B vaccine (method A and B).
Dobbelaer R; Daas A; Milne C
Pharmeuropa Bio; 2004 Jan; 2003(2):77-90. PubMed ID: 14960264
[TBL] [Abstract][Full Text] [Related]
12. [ON THE AGREEMENT OF THE ADVANTAGES OF PYROGEN ASSAY PROCEDURES OF THE BRITISH PHARMACOPOEIA 1958, RESPECTIVELY, BY THE AUSTRIAN PHARMACOPOEIA IX. 1960 AND THE U.S. PHARMACOPOEIA XVI. 1960].
SIMON S; VRABEL M
Arch Int Pharmacodyn Ther; 1963 Nov; 146():134-44. PubMed ID: 14077703
[No Abstract] [Full Text] [Related]
13. Implementing the Principle of the 3 Rs Through the Indian Pharmacopoeia.
Rastogi S; Kalaivani M; Bhatia AK; Prakash J; Singh GN
Ther Innov Regul Sci; 2015 Sep; 49(5):750-755. PubMed ID: 30227040
[TBL] [Abstract][Full Text] [Related]
14. Possibilities of replacing and reducing animal tests in the pharmacopoeias: an evaluation of unused methods and proposals for change.
Miethe G
Altern Lab Anim; 2002; 30(2):229-40. PubMed ID: 11971758
[TBL] [Abstract][Full Text] [Related]
15. Design and international harmonization of pharmacopoeial standards.
Calam DH
J Pharm Biomed Anal; 1995 Dec; 14(1-2):1-5. PubMed ID: 8833960
[TBL] [Abstract][Full Text] [Related]
16. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
[TBL] [Abstract][Full Text] [Related]
17. [The use of transgenic animals in biomedical research in Germany. Part 2: Ethical evaluation of the use of transgenic animals in biomedical research and perspectives for the changeover in research to research animal-free methods].
Sauer UG; Kolar R; Rusche B
ALTEX; 2006; 23(1):3-16. PubMed ID: 16477343
[TBL] [Abstract][Full Text] [Related]
18. [Application of thermal analysis to quality evaluation tests of drugs].
Komatsu H; Yoshii K; Okada S
Eisei Shikenjo Hokoku; 1996; (114):147-9. PubMed ID: 9037889
[TBL] [Abstract][Full Text] [Related]
19. Progress and problems in the replacement of in vivo pharmacopoeial bioassays for hormones.
Bristow AF; Charton E
Dev Biol (Basel); 2002; 111():79-88. PubMed ID: 12678227
[TBL] [Abstract][Full Text] [Related]
20. Role and functions of the International Pharmacopoeia.
Wieniawski W
Ann Ist Super Sanita; 1975; 11(3-4):204-10. PubMed ID: 1234722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
